David J. Wustrow
Corporate Officer/Principal chez RAPT THERAPEUTICS, INC.
Postes actifs de David J. Wustrow
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RAPT THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 | - |
Historique de carrière de David J. Wustrow
Anciens postes connus de David J. Wustrow
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/06/2012 | 01/02/2016 |
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2008 | 01/01/2012 |
| Neurogen Technologies, Inc. | Corporate Officer/Principal | 01/01/2005 | 01/01/2008 |
| Pfizer NV/SA | Corporate Officer/Principal | 01/10/1989 | 01/10/2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2005 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Corporate Officer/Principal | - | - |
Formation de David J. Wustrow
| Rochester Christian University | Doctorate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Belgique | 2 |
Opérationnelle
| Corporate Officer/Principal | 7 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
| Pfizer NV/SA | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
| Neurogen Technologies, Inc. |
- Bourse
- Insiders
- David J. Wustrow
- Expérience
